Full CoveragePopular ‘miracle’ weight loss drug is causing people to lose their vision, lawsuits claim
By Anthony G. Attrino
Top news
Ozempic and vision loss: GLP-1 drugs may double risk of eye disease
By Corrie Pelc
A link between some weight loss drugs and potentially blinding eye disease — and more
By Katharin Czink, Lourdes Duarte & Ben Bradley
Neovascular macular degeneration risk increased by semaglutide use
By Krish Singh
All coverage
GLP-1 Receptor Agonists Could Reduce Risk of Glaucoma in Type 2 Diabetes
By Julia Bonavitacola
GLP-1 Receptor Agonists Linked to Double Risk of Neovascular Age-Related Macular Degeneration in Diabetic Patients
By Mark Chiang
GLP-1 Drugs Double Risk of Neovascular Age-Related Macular Degeneration in Diabetic Patients
By Mark Chiang
Ozempic, Wegovy Users Want NJ To Host Vision-Loss Suits
By Carla Baranauckas